CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for Helicobacter pylori eradication

Hybrid Therapy Regimen for Helicobacter Pylori Eradication

(2016) Li-Ya Zhou et al.   CHINESE MEDICAL JOURNAL

Hybrid Therapy as First-Line Regimen forHelicobacter pyloriEradication in Populations with High Antibiotic Resistance Rates

(2016) Zhiqiang Song et al.   HELICOBACTER

Hybrid, sequential and concomitant therapies forHelicobacter pylorieradication: A systematic review and meta-analysis

(2016) Zhi-Qiang Song et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The interleukin (IL)-1 cytokine family – Balance between agonists and antagonists in inflammatory diseases

(2015) Jennifer Palomo et al.   CYTOKINE

Meta-Analysis of Sequential, Concomitant and Hybrid Therapy for Helicobacter pylori Eradication

(2015) Lei He et al.   INTERNAL MEDICINE

Concomitant and hybrid therapy forHelicobacter pyloriinfection: A randomized clinical trial

(2015) Jun Heo et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection

(2015) Ping-I Hsu et al.   MEDICINE

Hybrid therapy forHelicobacter pyloriinfection: A systemic review and meta-analysis

(2015) Ping-I Hsu   WORLD JOURNAL OF GASTROENTEROLOGY

Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients

(2014) Zhiqiang Song et al.   DIGESTIVE AND LIVER DISEASE

Efficacy of tailoredHelicobacter pylorieradication therapy based on antibiotic susceptibility andCYP2C19genotype

(2014) Mitsushige Sugimoto   WORLD JOURNAL OF GASTROENTEROLOGY

Helicobacter pylori: Future perspectives in therapy reflecting three decades of experience

(2014) Tajana Filipec Kanizaj   WORLD JOURNAL OF GASTROENTEROLOGY

Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance

(2013) Javier Molina–Infante et al.   GASTROENTEROLOGY

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

(2012) Francis Megraud et al.   GUT

Helicobacter pylori and Nonmalignant Diseases

(2011) Alaa Alakkari et al.   HELICOBACTER

Modified Sequential Helicobacter pylori Therapy: Proton Pump Inhibitor and Amoxicillin for 14 Days with Clarithromycin and Metronidazole added as a Quadruple (Hybrid) Therapy for the Final 7 Days

(2011) Ping-I. Hsu et al.   HELICOBACTER

Helicobacter pylori treatment in the era of increasing antibiotic resistance

(2010) D. Y. Graham et al.   GUT

Second Asia-Pacific Consensus Guidelines forHelicobacter pyloriinfection

(2009) K Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY